TG Therapeutics Inc. (TGTX) surged 5.01% intraday on Thursday, driven by optimism over its high growth prospects and significant upside potential.
According to a MarketWatch analysis, TGTX is among 25 small-cap stocks projected to achieve a 40% compound annual growth rate (CAGR) in revenue through 2027. Analysts also see a 52% upside potential for the stock, with a consensus price target of $44.86 compared to its recent price of $29.54.
The strong growth projections and bullish price targets have attracted investor interest, fueling the stock's upward movement during the trading session.